ARTICLE | Clinical News
BVF-033 regulatory update
October 29, 2007 7:00 AM UTC
BVF submitted a complete response to FDA in response to a July not approvable letter for BVF-033 to treat depression. The company said the submission includes new analyses of the data included in the ...